Phonological activation in anaphoric lexical access (ALA).

PubWeight™: 0.81‹?›

🔗 View Article (PMID 10433737)

Published in Brain Lang on October 21, 1999

Authors

J Simner1, R Smyth

Author Affiliations

1: University of Sussex, Falmer, Brighton, United Kingdom. jools@biols.susx.ac.uk

Articles citing this

Binding in agrammatic aphasia: Processing to comprehension. Aphasiology (2010) 1.04

Filling the Silence: Reactivation, not Reconstruction. Front Psychol (2016) 0.75

Articles by these authors

Epidural versus non-epidural or no analgesia in labour. Cochrane Database Syst Rev (2005) 2.21

Evaluation of a cefoxitin 30 microg disc on Iso-Sensitest agar for detection of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother (2003) 1.91

Relapse into mania or depression following lithium discontinuation: a 7-year follow-up. Acta Psychiatr Scand (2004) 1.45

Idiopathic pulmonary fibrosis in infants: good prognosis with conservative management. Arch Dis Child (2000) 1.39

Survival and quality of life of cystic fibrosis patients before and after heart-lung transplantation. Transplant Proc (1991) 1.33

Phenotypic detection of methicillin resistance in Staphylococcus aureus by disk diffusion testing and Etest on Mueller-Hinton agar. J Clin Microbiol (2006) 1.33

Evaluation of cefoxitin 5 and 10 microg discs for the detection of methicillin resistance in staphylococci. J Antimicrob Chemother (2005) 1.28

Evaluation of four selective agars and two enrichment broths in screening for methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2008) 1.26

Passive smoking and impaired lung function in cystic fibrosis. Arch Dis Child (1994) 1.11

Who is referred to neurology clinics?--the diagnoses made in 3781 new patients. Clin Neurol Neurosurg (2010) 1.08

Factors affecting the outcome of methadone maintenance treatment in opiate dependence. Ir Med J (2007) 1.07

Symptoms 'unexplained by organic disease' in 1144 new neurology out-patients: how often does the diagnosis change at follow-up? Brain (2009) 1.06

Heart-lung transplantation for end-stage respiratory disease in patients with cystic fibrosis at Papworth Hospital. J Heart Lung Transplant (1994) 1.06

Interventions for varicose veins and leg oedema in pregnancy. Cochrane Database Syst Rev (2007) 1.03

Markers of experimental acute inflammation in the Wistar Han rat with particular reference to haptoglobin and C-reactive protein. Arch Toxicol (2003) 0.97

Endobronchial tumours in childhood. Eur J Radiol (1998) 0.97

Vaccines for preventing influenza in people with cystic fibrosis. Cochrane Database Syst Rev (2000) 0.97

Effect of acute induced metabolic alkalosis on 800-m racing time. Med Sci Sports Exerc (1983) 0.96

Neurology out-patients with symptoms unexplained by disease: illness beliefs and financial benefits predict 1-year outcome. Psychol Med (2009) 0.92

Kawasaki disease associated with varicella: a rare association. Br J Dermatol (1999) 0.89

Heart and lung transplantation for terminal cystic fibrosis. A 4 1/2-year experience. J Thorac Cardiovasc Surg (1991) 0.88

Trends in passive smoking in cystic fibrosis, 1993-1998. Pediatr Pulmonol (2001) 0.86

Introduction to tripartite meeting report (convenors: Dr Nigel Baber and Prof. Ros Smyth): towards establishing optimal doses for drugs prescribed to children. Br J Clin Pharmacol (2005) 0.85

Oral steroids for cystic fibrosis. Cochrane Database Syst Rev (2000) 0.83

Cross-correlation of cyclosporine concentrations and biochemical measures of kidney and liver function in heart and heart-lung transplant recipients. Clin Chem (1990) 0.83

Detection and identification of Staphylococcus lugdunensis are not hampered by use of defibrinated horse blood in blood agar plates. J Clin Microbiol (2010) 0.81

Extending the clinical research network approach to all of healthcare. Ann Oncol (2011) 0.81

Early graft function following heart and lung transplantation. Transpl Int (1989) 0.80

Intensive care management of children following heart and heart-lung transplantation. Intensive Care Med (1990) 0.78

Fetal vibroacoustic stimulation for facilitation of tests of fetal wellbeing. Cochrane Database Syst Rev (2001) 0.78

Ursodeoxycholic acid in cystic fibrosis-related liver disease: a systematic review. J R Soc Med (1997) 0.78

Systematic review of antistaphylococcal antibiotic therapy in cystic fibrosis. Thorax (2000) 0.77

Some factors affecting accuracy of Canadian Home Fitness Test scores. Can J Appl Sport Sci (1979) 0.77

Ursodeoxycholic acid for cystic fibrosis-related liver disease. Cochrane Database Syst Rev (2000) 0.77

Vibroacoustic stimulation for fetal assessment in labour in the presence of a nonreassuring fetal heart rate trace. Cochrane Database Syst Rev (2005) 0.77

Systematic review of nebulized antibiotics in cystic fibrosis: evolution of protocol. J R Soc Med (1998) 0.75

Early graft function after heart-lung transplantation. J Heart Transplant (1991) 0.75

Histologic prognostic indicators for the lung allografts of heart-lung transplants. J Heart Transplant (1990) 0.75

[Clinical applications of the heart-lung transplant. Clinical results 5 years after the start of the program at Papworth]. G Ital Cardiol (1989) 0.75

Culture of Candida albicans on gonococcal and Sabouraud's media correlated with presence or absence of signs or symptoms and positive results on microscopy and cytology. Genitourin Med (1985) 0.75

General vs regional anaesthesia for minor surgery. Can J Anaesth (1993) 0.75

Effects of temperature on the detection of methicillin resistance in Staphylococcus aureus using cefoxitin disc diffusion testing with Iso-Sensitest agar. J Antimicrob Chemother (2009) 0.75

Direction-sensitive simultaneous multivelocity component LDV. Appl Opt (1978) 0.75

Book review: Oral medicine: Update for the dental team. Br Dent J (2015) 0.75